𝗪𝗲𝗹𝗰𝗼𝗺𝗲 𝘁𝗼 𝘁𝗵𝗲 𝟮𝗻𝗱 𝗺𝗥𝗡𝗔 𝗔𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝗮𝗹 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗦𝘂𝗺𝗺𝗶𝘁: 𝗧𝗿𝗮𝗶𝗹𝗯𝗹𝗮𝘇𝗶𝗻𝗴 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗔𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝘀 𝗳𝗼𝗿 𝗦𝘂𝗽𝗲𝗿𝗶𝗼𝗿 𝗺𝗥𝗡𝗔 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 and 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀

Uniting 80+ Senior Scientists, Directors, and Heads of Analytical Development, Quality Control, CMC and Regulatory – join us in Boston alongside pioneering speakers from innovative biopharma and KOLs of academia.

Avoid missing out on networking with those shaping the landscape of novel and emerging analytical tools and technologies for mRNA-based therapeutics and vaccines. Meet your community face-to-face in 2023 to hear how they address the major challenges facing the industry:

𝗘𝘅𝗽𝗹𝗼𝗿𝗲 𝗘𝗺𝗲𝗿𝗴𝗶𝗻𝗴 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀 and 𝗡𝗼𝘃𝗲𝗹 𝗔𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝗮𝗹 𝗔𝗽𝗽𝗿𝗼𝗮𝗰𝗵𝗲𝘀 𝗳𝗼𝗿 𝗺𝗥𝗡𝗔 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 and 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀

With mRNA therapeutics and vaccines disrupting the industry, hear from the likes of Beam Therapeutics, Merck, and Pfizer on where innovation is expected to come from and discuss the opportunities emerging analytical and biological technologies offer over traditional methods

𝗜𝗺𝗽𝗿𝗼𝘃𝗲 𝗖𝗵𝗲𝗺𝗶𝗰𝗮𝗹-𝗕𝗮𝘀𝗲𝗱 𝗔𝘀𝘀𝗮𝘆𝘀 and 𝗡𝗮𝗻𝗼𝗳𝗼𝗿𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗳𝗼𝗿 𝗥𝗡𝗔-𝗯𝗮𝘀𝗲𝗱 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀 and 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀

This meeting will shine the spotlight on novel analytical techniques for RNA-based therapeutics and vaccines and emerge into innovating nanoformulation as well as unravel the interaction between the drug product and cell with research institutes and companies including GSK, MIT, and CureVac

𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗘𝘅𝗽𝗲𝗰𝘁𝗮𝘁𝗶𝗼𝗻𝘀 and 𝗘𝘀𝘁𝗮𝗯𝗹𝗶𝘀𝗵 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗦𝘂𝗰𝗰𝗲𝘀𝘀 𝘄𝗶𝘁𝗵 𝗘𝗺𝗲𝗿𝗴𝗶𝗻𝗴 𝗔𝘀𝘀𝗮𝘆𝘀 and 𝗔𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝗮𝗹 𝗧𝗼𝗼𝗹𝘀

Explore the FDA's personal perspective of common mistakes observed in regulatory submissions for analytical method validation and real-world examples of physicochemical methods previously submitted for biological drug testing

𝗢𝘃𝗲𝗿𝗰𝗼𝗺𝗲 𝗦𝗰𝗮𝗹𝗲-𝗨𝗽 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀 and 𝗘𝗺𝗲𝗿𝗴𝗲 𝗶𝗻𝘁𝗼 𝗕𝗶𝗼𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝗮𝗹 𝗜𝗺𝗺𝘂𝗻𝗼𝗹𝗼𝗴𝘆

Discuss how to overcome analytical and scale-up challenges of emerging RNA modalities and how to find the balance between high immunoreactivity and low toxicity with insights from Ziphius Vaccines, BioNTech, and Replicate Bioscience

𝗗𝗲𝗹𝘃𝗲 𝗶𝗻𝘁𝗼 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗺𝗲𝗻𝘁𝘀 𝗶𝗻 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗖𝗵𝗮𝗿𝗮𝗰𝘁𝗲𝗿𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗧𝗼𝗼𝗹𝘀 𝗳𝗼𝗿 𝗺𝗥𝗡𝗔-𝗕𝗮𝘀𝗲𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 and 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀

Delve into pioneering approaches to characterize and purify RNA in lipid nanoparticles intended for base editing with Beam Therapeutics, Arcturus Therapeutics, and Seqirus

Join us February 14-16, 202 in Boston, MA!

Time: 08:00 to 19:00

Continue reading at mrna-analytical-development.com

Health and Wellness

Facebook Share

Twitter Share

Linkedin Share

Email Share